Roderick H. Mac Leod is SVP, Chief Financial Officer of NEVRO CORP. Currently has a direct ownership of 133,934 shares of NVRO, which is worth approximately $776,817. The most recent transaction as insider was on Sep 07, 2024, when has been sold 1,759 shares (Common Stock) at a price of $5.18 per share, resulting in proceeds of $9,111. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 134K
1.89% 3M change
102.39% 12M change
Total Value Held $776,817

Roderick H. MacLeod Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 07 2024
SELL
Payment of exercise price or tax liability
$9,111 $5.18 p/Share
1,759 Reduced 1.3%
133,934 Common Stock
Aug 28 2024
SELL
Payment of exercise price or tax liability
$4,705 $5.76 p/Share
817 Reduced 0.6%
135,693 Common Stock
Jun 15 2024
SELL
Payment of exercise price or tax liability
$14,619 $9.03 p/Share
1,619 Reduced 1.17%
136,510 Common Stock
Jun 07 2024
SELL
Payment of exercise price or tax liability
$16,305 $9.27 p/Share
1,759 Reduced 1.26%
138,129 Common Stock
May 28 2024
SELL
Payment of exercise price or tax liability
$7,768 $9.52 p/Share
816 Reduced 0.58%
139,888 Common Stock
Mar 07 2024
SELL
Payment of exercise price or tax liability
$109,323 $15.32 p/Share
7,136 Reduced 4.83%
140,704 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
84,326 Added 36.32%
147,840 Common Stock
Mar 04 2024
SELL
Payment of exercise price or tax liability
$6,355 $14.51 p/Share
438 Reduced 0.68%
63,514 Common Stock
Mar 04 2024
BUY
Grant, award, or other acquisition
-
743 Added 1.15%
63,952 Common Stock
Mar 02 2024
SELL
Payment of exercise price or tax liability
$18,059 $14.22 p/Share
1,270 Reduced 1.97%
63,209 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$13,308 $14.82 p/Share
898 Reduced 1.37%
64,479 Common Stock
Nov 28 2023
SELL
Payment of exercise price or tax liability
$13,336 $16.67 p/Share
800 Reduced 1.21%
65,377 Common Stock
Aug 28 2023
SELL
Payment of exercise price or tax liability
$15,512 $19.39 p/Share
800 Reduced 1.19%
66,177 Common Stock
Jun 15 2023
SELL
Payment of exercise price or tax liability
$39,577 $24.97 p/Share
1,585 Reduced 2.31%
66,977 Common Stock
May 28 2023
SELL
Payment of exercise price or tax liability
$21,160 $26.45 p/Share
800 Reduced 1.15%
68,562 Common Stock
Mar 07 2023
BUY
Grant, award, or other acquisition
-
39,282 Added 36.16%
69,362 Common Stock
Mar 02 2023
SELL
Payment of exercise price or tax liability
$38,510 $33.99 p/Share
1,133 Reduced 3.63%
30,080 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$105,386 $31.44 p/Share
3,352 Reduced 9.7%
31,213 Common Stock
Jun 15 2022
SELL
Payment of exercise price or tax liability
$66,713 $42.25 p/Share
1,579 Reduced 4.37%
34,565 Common Stock
Mar 02 2022
SELL
Payment of exercise price or tax liability
$84,526 $71.27 p/Share
1,186 Reduced 3.18%
36,144 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
18,249 Added 32.83%
37,330 Common Stock
Jun 15 2021
SELL
Payment of exercise price or tax liability
$250,890 $158.49 p/Share
1,583 Reduced 7.66%
19,081 Common Stock
Mar 02 2021
BUY
Grant, award, or other acquisition
-
8,612 Added 29.42%
20,664 Common Stock
RHM

Roderick H. Mac Leod

SVP, Chief Financial Officer
Redwood City, CA

Track Institutional and Insider Activities on NVRO

Follow NEVRO CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVRO shares.

Notify only if

Insider Trading

Get notified when an Nevro Corp insider buys or sells NVRO shares.

Notify only if

News

Receive news related to NEVRO CORP

Track Activities on NVRO